Company / Revenue per Share
CLOVER HEALTH INVESTMENTS, CORP. /DE Revenue per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$3.99
FY2025
5-year range
$2.61 / $16.76
FY2021-FY2025
Trend
+42.6%
vs FY2024
Sector context
#138 of 154
Health Care
What the data says
Among 154 Health Care companies, CLOVER HEALTH INVESTMENTS, CORP. /DE is in the bottom 10% for revenue per share. Improved from $2.61 to $3.99 over the past 2 years.
Based on SEC 10-K filings.
3.99 in FY2025 with a 5-year CAGR of -12.1%.
Improved from $2.61 to $3.99 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -31.4%
- 5-Year CAGR
- -12.1%
- 10-Year CAGR
- -
Sector benchmark
Bottom 10% in Health CareTop 90% of 154This company $3.99 Sector average $123.99
▼
-96.8% below sector average
Key checks
Key Insights
- In FY2025, revenue per share increased 42.6% year-over-year.
- Ranks #138 out of 154 companies in the Health Care sector.
- Peak revenue per share was recorded in FY2021.
- Lowest revenue per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.99 | +42.6% |
| FY2024 | $2.80 | +7.0% |
| FY2023 | $2.61 | -78.9% |
| FY2022 | $12.36 | -26.2% |
| FY2021 | $16.76 | +120.9% |
| FY2020 | $7.59 | +44.1% |
| FY2019 | $5.26 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026